AN2 Therapeutics, Inc. (ANTX)

4.50 -0.25 (-5.26%) USD  |  NASDAQ  |  May 18, 16:00
4.43 -0.07 (-1.56%) After-Hours: 20:00
More

AN2 Therapeutics EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Relmada Therapeutics, Inc. --
Corcept Therapeutics, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade